iNtRON Biotechnology Major Shareholder Yun Seong-jun Reports Partial Change in Stock Pledge Agreement
Major shareholder Yun Seong-jun filed a change report due to a partial modification of the stock pledge agreement as of July 20, 2026.
The reported shareholding remains unchanged at 5,815,096 shares, representing 18.82% of total shares, identical to the previous report.
Shares under major contracts decreased from 2,305,106 to 1,782,971, with a new pledge of 506,465 shares.
This report is a routine administrative update with no impact on capital structure or management control.
[AI Summary]This change report reflects a partial modification of the major shareholder's stock pledge agreement. As there is no change in beneficial ownership, shareholder value is not materially affected. Limited near-term stock price impact.